The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a structured quality management program on survival of patients with advanced (AOC) and relapsed ovarian cancer (ROC) treated in a dedicated tertiary gynecologic-oncology (GO) center.
 
Philipp Harter
Honoraria - AstraZeneca; Lilly; PharmaMar; Roche; Stryker; Tesaro; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Lilly; PharmaMar; Roche; Tesaro
 
Florian Heitz
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Tesaro
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - PharmaMar; Tesaro
 
Beyhan Ataseven
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca; Roche
Travel, Accommodations, Expenses - Roche; Teva
 
Sonia Prader
No Relationships to Disclose
 
Stefanie Schneider
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Thaïs Baert
Consulting or Advisory Role - Tesaro
Research Funding - Amgen
Patents, Royalties, Other Intellectual Property - Patent pending for a diagnostic PBMC panel in ovarian cancer (Inst)
Travel, Accommodations, Expenses - Amgen; Roche
 
Pier Alesina
No Relationships to Disclose
 
Harald Groeben
No Relationships to Disclose
 
Alexander Traut
No Relationships to Disclose
 
Andreas Du Bois
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; Genmab; Pfizer; Roche/Genentech; Tesaro